Compare Stocks

The Chiba Bank, Ltd., together with its subsidiaries, provides banking products and services in Japan and internationally. The company offers various deposit products, including savings, time deposits, currency deposits, investment trusts, bonds, and pensions; loans, which include mortgages, renovation loans, photovoltaic, vehicle, education, and other loan products; and insurance products, such as annuity, life, medical, student, death, and travel insurance. It also offers debit and credit cards, as well as internet banking services. In addition, the company engages in securities, investment management and advisory, software development, commissioned computation tasks, research and investigation of IT and financial technologies, leasing, operation, and management of investment funds, mergers and acquisition advisory, credit guarantee businesses, management and collection of claims businesses. Further, it provides loan guarantees and fee collection services; accounting, general administration entrustment, and temporary staff services; and is involved in outsourcing of operational business. Additionally, it rents and maintains office buildings and welfare facilities; provides research, survey, and consulting services; purchases and sells supplies and consumer goods; and engages in renewable energy generation. The company serves individuals and corporations. The Chiba Bank, Ltd. was incorporated in 1943 and is headquartered in Chiba City, Japan.

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Orbia Advance Corporation, S.A.B. de C.V. provides products and solutions for precision agriculture, building and infrastructure, fluorinated, polymer, and connectivity sectors worldwide. The company offers irrigation systems, agricultural and greenhouse projects, digital farming technologies, and related services; and connectivity solutions, including conduits, cable-in conduit, and other HDPE products and solutions. It also provides water delivering solutions for drinking water supply, sanitation, and urban water resilience; fluorine and downstream products, comprising fluorspar mine and produces intermediates, refrigerants, and propellants for used in automotive, infrastructure, semiconductor, health, medicine, climate control, food cold chain, energy storage, computing, and telecommunications applications; and general and specialty resins, PVC, and compounds and additives for stabilizers and plasticizers, as well as compounds formulated from polyolefin, thermoplastic polyurethane, and thermoplastic elastomer polymers for various applications. The company was formerly known as Mexichem, S.A.B. de C.V. and changed its name to Orbia Advance Corporation, S.A.B. de C.V. in August 2019. Orbia Advance Corporation, S.A.B. de C.V. was founded in 1953 and is headquartered in Mexico City, Mexico.

Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. The company offers co-ordinate measuring machine products, hardware, software, retrofits, machine tool probes, diagnostics, encoders, tool setters, performance measurement systems, gauging systems, modular and custom fixtures, and styli products for touch probe systems; machine calibration and optimization products; interferometric laser, magnetic, and open and enclosed optical encoders; and additive manufacturing systems. It also provides healthcare products, such as neurosurgical robots and accessories, neurosurgical planning software, electrode delivery systems, drug delivery systems, Raman microscopes, analysers, and hybrid Raman systems. In addition, the company offers smart manufacturing data platform and asset financing services. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is headquartered in Wotton-under-Edge, the United Kingdom.

Shizuoka Financial Group,Inc., together with its subsidiaries, provides various banking products and services. The company operates through Banking Operations and Leasing Operations segments. It engages in the banking business centered on deposits, loans, investment securities, and exchange transactions. The company is also involved in the lease transactions centered on finance leases. In addition, it offers corporate and financial management advisory, and bill collection services; computer system development and operation, fee-based job placement, and general administration services. Further, the company engages in the guarantee of housing loans and consumer loans, etc.; purchase of monetary receivables; appraisal of real estate for loan collateral; operation of centers for loans, remittance, and bill collection; and making, printing, and binding of various documents. Additionally, it offers credit cards services; public-offering assistance support services for corporate rehabilitation; part-time employee management services; and finance and securities-related services. As of July 1, 2022, the company operated through a network of head office and 177 branches, and 25 sub-branches in Japan; 1 branch in New York and a representative office in Silicon Valley; and 2 branches in Hong Kong and Singapore, and 1 representative office in Shanghai. The company was formerly known as The Shizuoka Bank, Ltd. Shizuoka Financial Group,Inc. was founded in 1943 and is headquartered in Shizuoka, Japan.